fund
This is one of our rated funds. They’re the ones our experts believe will do well for investors over the longer term. Top of the class!
Morgan Stanley US Advantage F GBP
-
2590.47p
Price (Inc)
These are the shares in the fund that pay out an income to clients. The income is made up of the total dividends – the money a company can pay out to its investors – from the companies in the fund.
-
-
Price (Acc)
These are the shares in the fund that don’t pay out an income to clients. Any dividends – the money a company can pay out to its investors – are reinvested into companies in the fund. Despite no income, the shares should be worth more over time. Good incentive, eh?
-
0.00%
Initial chargeSome funds charge you when you first invest, which is aptly known as the initial charge. They’re usually between 3-5% but at Bestinvest, we usually don’t charge you a penny!
-
0.40%
Annual management charge
This is how much the fund management company charges to run the fund. It’s like paying a babysitter, dog sitter or house sitter (that makes well-informed, heavily researched changes to improve your baby/dog/house when needed).
-
0.55%
Ongoing charges
This stands for Ongoing Charges Figure. It’s the cost of running a fund and includes admin fees, manager fees, administration costs, etc.
-
0.10%
Yield
How much the fund is currently paying out in income to investors. It’s NOT to be confused with the overall growth of a fund – a very different thing indeed. It’s also NOT a guarantee of future pay-outs, just a snapshot. This is more what it’s not than what it is…
The fund’s investment objective is to achieve capital growth principally through investment in the securities of companies listed in the United States. The manager aims to outperform the S&P 500 Index over rolling three to five-year periods. The fund is large-cap in nature and will typically invest in established companies which can grow sustainably and have enduring competitive advantages. It is managed by Dennis Lynch at New York-based Counterpoint Global, an autonomous investment boutique within Morgan Stanley Investment Management.
Fund summary
| Sector | North America |
| Structure | OEIC |
| Launched | |
| Size | £1,091m |
| Yield | 0.10% |
| Charging basis | Income |
| Dividends paid | Acc units only |
Charges
| Standard initial charge | 0.00% |
| Initial charge via Bestinvest | 0.00% |
| Annual management charge | 0.40% |
| Ongoing charges figure | 0.55% |
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Investment process
The investable universe is established companies within the market cap range of the S&P 500. The investment process is entirely bottom-up and driven by proprietary fundamental research. The team believe that market inefficiencies exist and that they are localised in certain areas of the market due to certain systematic biases, such as short-term bias or stocks with a relative lack of sell-side coverage. Ideas are generated from a range of sources but aside from looking at ROIC and free cash flow yield the process is largely qualitative, with the team preferring to focus on characteristics that can’t easily be quantified. The analysis stage looks to identify unique companies that can sustain growth over the long term. Valuation is important and when producing price targets they take a five and ten year view, consequently the fund can trade on high current P/E multiples.
Counterpoint Global, the fund manager, is a growth-focused US equity boutique sat within Morgan Stanley Investment Management. US Advantage is the least “growthy” of the large-cap strategies that the team manage. The portfoliio is focused on steady growth businesses with sustainable competitive advantages, such as strong brands, scale, network effects, or advanced technology or IP. The fund stands out due to the stability and strength of the team, the investment culture within Counterpoint Global and a process that has some differentiating features. This has led to a track record that is impressive versus the S&P 500 and the growth peer group over more than a decade
Manager research
Average monthly relative returns
- 16/17 0.00%
- 17/18 0.00%
- 18/19 0.00%
- 19/20 0.00%
- 20/21 0.00%
Bestinvest MRI
- 3 years 0.00%
- 5 years 0.00%
- Career 0.00%
- 3 years 0.00%
- 5 years 0.00%
- Career 0.00%
Performance figures are based on the average of monthly percentage returns relative to the benchmark index.
Track record
Periods of worst performance
| Absolute | 0.00% () |
| Relative | 0.00% () |
About the MRI
Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Allocation
Proportion (%)
-
{{chartDataItem.text}}{{chartDataItem.value}}
Portfolio
30-40 stocks
Key Investor Information